Acorah Software Products - Accounts Production16.1.200falsetruefalsetrueNo description of principal activity10 November 202330 November 202430 November 202415274104Mr Xianhong XuMrs Yating Maiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure152741042023-11-09152741042024-11-30152741042023-11-102024-11-3015274104frs-core:CurrentFinancialInstruments2024-11-3015274104frs-bus:PrivateLimitedCompanyLtd2023-11-102024-11-3015274104frs-bus:FilletedAccounts2023-11-102024-11-3015274104frs-bus:Micro-entities2023-11-102024-11-3015274104frs-bus:AuditExempt-NoAccountantsReport2023-11-102024-11-3015274104frs-bus:Director12023-11-102024-11-3015274104frs-bus:CompanySecretary12023-11-102024-11-30
Registered number: 15274104
Biodigicine Technology Ltd
Unaudited Financial Statements
For the Period 10 November 2023 to 30 November 2024
Dolan Accountancy Limited
Biodigicine Technology Ltd
Balance Sheet
As At 30 November 2024
Balance Sheet
Registered number: 15274104
30 November 2024
£
Fixed assets
728
Current assets
38,022
Creditors: Amounts Falling Due Within One Year
(26,458)
NET CURRENT ASSETS
11,564
TOTAL ASSETS LESS CURRENT LIABILITIES
12,292
NET ASSETS
12,292
CAPITAL AND RESERVES
12,292
Notes
1.General Information
Biodigicine Technology Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15274104. The registered office is Unit 36 Silk Mill Industrial Estate, Brook Street, Tring, HP23 5EF.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.